Antibiotic strategies in the era of multidrug resistance, Crit Care, vol.20, p.136, 2016. ,
Advances in antibiotic therapy in the critically ill, Crit Care, vol.20, 2016. ,
A high-dose aminoglycoside regimen combined with renal replacement therapy for the treatment of MDR pathogens: a proof-of-concept study, J Antimicrob Chemother, vol.71, pp.1386-94, 2016. ,
Higher than recommended amikacin loading doses achieve pharmacokinetic targets without associated toxicity, Int J Antimicrob Agents, vol.38, pp.146-51, 2011. ,
Therapeutic drug monitoring of amikacin in septic patients, Crit Care, vol.17, p.165, 2013. ,
Amikacin Monotherapy for Sepsis Caused by Panresistant Pseudomonas aeruginosa, Antimicrob Agents Chemother, vol.54, pp.4939-4980, 2010. ,
Optimising amikacin regimens in septic patients, Int J Antimicrob Agents, vol.39, pp.264-269, 2012. ,
Revisiting the loading dose of amikacin for patients with severe sepsis and septic shock, Crit Care, vol.14, p.53, 2010. ,
The association of aminoglycoside plasma levels with mortality in patients with gram-negative bacteremia, J Infect Dis, vol.149, pp.443-451, 1984. ,
Committee on Antimicrobial Susceptibility Testing Breakpoint tables for interpretation of MICs and zone diameters, 2016. ,
Impact of 30 mg/kg amikacin and 8 mg/kg gentamicin on serum concentrations in critically ill patients with severe sepsis, J Antimicrob Chemother, vol.71, pp.208-220, 2016. ,
URL : https://hal.archives-ouvertes.fr/hal-01912185
Prospective Evaluation of the Effect of an Aminoglycoside Dosing Regimen on Rates of Observed Nephrotoxicity and Ototoxicity, Antimicrob Agents Chemother, vol.43, pp.1549-55, 1999. ,
Section I -Emergency Care, pp.1-294, 2012. ,
Chapter 1 -Applied Physiology of Body Fluids in Dogs and Cats. Fluid Electrolyte Acid-Base Disord, Small Anim. Pract. Fourth Ed, pp.2-25, 2012. ,
Renal clearance of endogenous creatinine and urea in sheep during summer and winter, Res Vet Sci, vol.36, pp.220-224, 1984. ,
Mise au point sur le bon usage des aminosides administrés par voie injectable : gentamicine, tobramycine, nétilmicine, amikacine, 2011. ,
Pharmacokinetics of a loading dose of amikacin in septic patients undergoing continuous renal replacement therapy, Int J Antimicrob Agents, vol.37, pp.531-536, 2011. ,
URL : https://hal.archives-ouvertes.fr/hal-00690059
Accurate detection of outliers and subpopulations with Pmetrics, a non-parametric and parametric pharmacometric modeling and simulation package for R, Ther Drug Monit, vol.34, pp.467-76, 2012. ,
Prediction-corrected visual predictive checks for diagnosing nonlinear mixed-effects models, AAPS J, vol.13, pp.143-51, 2011. ,
Comparative pharmacokinetics of amikacin sulphate in calves and sheep, Res Vet Sci, vol.48, pp.231-235, 1990. ,
Pharmacokinetics of amikacin in lactating sheep, Vet Res Commun, vol.28, pp.429-464, 2004. ,
An open prospective study of amikacin pharmacokinetics in critically ill patients during treatment with continuous venovenous haemodiafiltration, BMC Pharmacol Toxicol, vol.13, p.14, 2012. ,
Hemodialysis of amikacin in critically ill patients, Crit Care Med, vol.16, pp.517-537, 1988. ,
Adsorption of Amikacin, a Significant Mechanism of Elimination by Hemofiltration, Antimicrob Agents Chemother, vol.52, pp.1009-1022, 2008. ,
Comparison of hemodialysis and hemodiafiltration: A long-term longitudinal study, Kidney Int, vol.41, pp.1035-1075, 1992. ,
Amikacin Pharmacokinetics During Continuous Veno-Venous Hemodialysis, Infect Dis Ther, vol.2, pp.217-243, 2013. ,
A randomized crossover comparison of the hemodynamic response to intermittent hemodialysis and continuous hemofiltration in ICU patients with acute renal failure, Intensive Care Med, vol.22, pp.742-748, 1996. ,
Comparing continuous hemofiltration with hemodialysis in patients with severe acute renal failure, Am J Kidney Dis, vol.34, pp.424-456, 1999. ,
Haemodiafiltration, haemofiltration and haemodialysis for end-stage kidney disease ,
, Cochrane Database Syst Rev, vol.5, p.6258, 2015.
Continuous vs. intermittent hemodialysis: with which spin will my patient win?, Crit Care, vol.11, p.313, 2007. ,
Comparison of continuous and intermittent renal replacement therapy for acute renal failure, Nephrol Dial Transplant, vol.20, pp.1630-1637, 2005. ,
Back to the Future: Using Aminoglycosides Again and How to Dose Them Optimally, Clin Infect Dis, vol.45, pp.753-60, 2007. ,
Incidence of and significant risk factors for aminoglycoside-associated nephrotoxicity in patients dosed by using individualized pharmacokinetic monitoring, J Infect Dis, vol.167, pp.173-182, 1993. ,
Actualités en antibiothérapie -Aminosides toujours et encore: bon usage et suivi thérapeutique, Réanimation, vol.20, pp.290-298, 2010. ,
,
, Urinary Neutrophil Gelatinase-associated Lipocalin as a Marker for Identification of Acute Kidney Injury and Recovery in Dogs with Gentamicin-induced Nephrotoxicity, J Vet Intern Med, vol.30, pp.200-205, 2016.
Cardiovascular and Respiratory Effects of Xylazine in Sheep, Zentralblatt Für Veterinärmedizin Reihe A, vol.25, pp.173-80, 1978. ,
Actions of xylazine in young swine, Am J Vet Res, vol.58, pp.99-102, 1997. ,
Pharmacokinetics of antibiotics in critically ill patients, Intensive Care Med, vol.16, pp.235-243, 1990. ,
The Merck Veterinary Manual. 11th Edition. Merck publishing, 2016. ,